MedPath

Interleukin 20 and Periodontal Tisuue Destruction

Completed
Conditions
Periodontitis
Interventions
Other: biochemical analysis
Registration Number
NCT06091800
Lead Sponsor
Recep Tayyip Erdogan University
Brief Summary

Periodontitis is an inflammatory disease that causes destruction of periodontal tissues. IL-20, on the other hand, is known as a potent angiogenic, chemotactic, and pro-inflammatory cytokine associated with various chronic inflammatory disorders. IL-20 has a significant role in the regulation of osteoclastogenesis and osteoblastogenesis. The aim of this study was to evaluate the effect of IL-20 on periodontal destruction.

In the study, a total of 60 participants were included, 30 of whom were systemically and periodontally healthy (control group) and 30 of whom were systemically healthy and had periodontitis (periodontitis group). GCF and serum samples were collected from the participants for biochemical analysis. ELISA method was used to determine IL-20, TNF-α, IL1β/IL-10, RANKL/OPG and MMP8 levels

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • The following criteria were required for inclusion: being systemically healthy, not smoking, not using antibiotics or systemic corticosteroids within the previous three months, not being pregnant or nursing, not having a chronic inflammatory disease, not receiving periodontal therapy within the previous six months, and possessing at least 20 teeth
Exclusion Criteria
  • smoking, using antibiotics or systemic corticosteroids within the previous three months, pregnant, receiving periodontal therapy within the previous six months

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
periodontitis groupbiochemical analysisinterdental clinical attachment level ≥ 5 mm, probing pocket depth ≥ 6 mm, radiographic bone loss extending to the middle or apical thirds of the root, mid-crest defect, and a history of ≤4 teeth loss of periodontal origin
control group (periodontally healthy)biochemical analysisno attachment loss, probing pocket depth ≤ 3 mm, minimal bleeding on probing ≤ 10%, and no radiographic bone loss
Primary Outcome Measures
NameTimeMethod
concentration of biochemical findings in gingival crevicular fluid (GCF)june 2022-june 2023

IL-20, RANKL, OPG and RANKL/OPG values eveluated in GCF

concentration of biochemical findings in serum1 year

IL-20, RANKL, OPG, RANKL/OPG, MMP-8, TNF-α, IL-1β, IL-10 and IL-1β/IL-10

Secondary Outcome Measures
NameTimeMethod
value of periodontal clinical parameters were measured in mm1 year

probing pocket depth (PPD), clinical attachment loss (CAL) of all natural teeth of the patients

value of periodontal clinical parameters1 year

plaque index (PI) (Silness \& Löe), gingival index (GI) (Silness \& Löe) and bleeding on probing index (BOP) of all natural teeth of the patients

Trial Locations

Locations (1)

Recep Tayyip Erdogan University

🇹🇷

Rize, Turkey

© Copyright 2025. All Rights Reserved by MedPath